Dow Up0.76% Nasdaq Up0.69%

InVivo Therapeutics Holdings Corp. (NVIV)

-Other OTC
0.91 Down 0.06(6.69%) Oct 24, 3:57PM EDT
ProfileGet Profile for:
InVivo Therapeutics Holdings Corp.
One Kendall Square
Suite B14402
Cambridge, MA 02139
United States - Map
Phone: 617-863-5500

Index Membership:N/A
Industry:Medical Appliances & Equipment
Full Time Employees:45

Business Summary 

Invivo Therapeutics Holdings Corp., a development stage biomaterials and biotechnology company, focuses on developing and commercializing technologies for the treatment of spinal cord injuries (SCI). The company is developing a biocompatible Neuro-Spinal Scaffold to treat acute SCI; and biocompatible Neuro-Spinal Scaffold Plus Stem Cells to treat chronic SCI. Its proprietary technologies incorporate intellectual property licensed under exclusive, worldwide license from ChildrenÂ’s Medical Center Corporation and the Massachusetts Institute of Technology, as well as intellectual property that has been developed internally in collaboration with advisors and partners. The company was founded in 2005 and is based in Cambridge, Massachusetts.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on InVivo Therapeutics Holdings Corp.

Key Executives 
Mr. Steven F. McAllister , 56
Chief Financial Officer
Mr. Mark D. Perrin , 57
Chief Exec. Officer and Director
Dr. Robert S. Langer Jr., Ph.D., Sc.D, 66
Co-Founder and Member of Scientific Advisory Board
Dr. Joseph P. Vacanti M.D., 65
Mr. William D'Agostino PE,
Sr. VP of Operations
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders